Abstract:Introduction: Rectal cancer is potentially curable condition but usually carries a poor prognosis because of local recurrence or distant metastasis. Neoadjuvant chemoradiation therapy (CRT) is often used for patients who have increased risk of circumferential resection margin involvement at surgery. Non-invasively methods for monitoring tumor response to preoperative CRT are mainly imaging based. New functional imaging techniques can potentially improve accuracy including diffusion-weighted imaging (DWI), dynamic contrast-enhanced MRI (DCE-MRI) and F-fluorodeoxyglucose (F-FDG) PET/CT. An increase of apparent diffusion coefficient (ADC), a quantitative parameter measured on DWI, suggests treatment-induced cell lysis and necrosis during the course of CRT. However, increase in ADC can also result from change in vessel permeability due to radiation therapy. For this, DCE-MRI may provide useful information regarding vascular permeability. On the other hand, late decrease in ADC is usually considered result of tissue compaction and fibrosis. But presence of residual active disease can also decrease ADC. Therefore, DWI alone might not distinguish between residual active disease and treatment-induced tumor fibrosis, which can be differentiated using PET/CT. The aim of this study was to investigate DWI, DCE-MRI and PET/CT for response assessment over a course of pre-operative combined CRT for primary rectal adenocarcinoma, to see if the combination of different techniques can best predict biological behavior and clinical outcome. Materials and Methods: 8 consecutive patients (6 men, 2 women, 54-73 years) suffering from rectal cancer of stage T3 or above were included in this study. Each patient received neoadjuvant chemoradiation preoperatively with 1.8Gy/fr daily 5fr/wk up to 50.4Gy. They underwent both MRI and PET/CT scans at three time points: baseline (before CRT), early mid treatment (2-week after start of CRT), and post-treatment (6-week after conclusion of CRT). All MRI and PET/CT were performed within one week interval (mean time interval: 2±1 days) at each time point. Total mesorectal excision (TME) was performed after completion of CRT and imaging scans. Radiographic changes were classified according to the Response Evaluation Criteria in Solid Tumors group (RECIST). Response was defined if complete or partial response was observed. Non-response was defined if progress or stable disease was observed. The differences of the imaging parameters between responders and non-responders were tested using the nonparametric Mann-Whitney test. The significance of changes of imaging parameters during therapy within a patient group was tested using a paired Wilcoxon test. Results: Patients and post-treatment changes are shown in table 1. Imaging parameters between response group and non-response group at different time points are shown in table 2. In figure 1, ADCmean changes of patients with data from all three time points in response group (solid lines) and non-response group (dotted lines) are shown in similar pattern except patient # 3, which was post-surgically confirmed to be mucous tumor. Mucinous tumors were known to behave differently and do not respond well to CRT, as suggested by the static ADCmean from baseline to the intermediate time point. K changes of patients with data from all three time points in response group (solid lines) are opposite to that of patients in non-response group (dotted lines) in figure 2. The change of mean K is consistent with the sharp increase of ADC from baseline to the intermediate time point for non-response group, suggesting the contributing value of increased vascular permeability to ADC measurement. In figure 3, SUVmax changes of patients in response group (solid lines) and non-response group (dotted lines) decreased from baseline to the final time point. However, there was no significant difference of SUVmax between responders and non-responders at the final time point. However, due to small sample size, we did not get any statistical significant results at present. Conclusion: From the limited data available from this study, we hypothesize that (1) in the early phase of CRT, the increase of ADC in responders represent treatment-induced apoptotic cell death and necrosis, whereas the increase of ADC in non-responders are result of vessel permeability after radiation. (2) The inflammation-induced SUV increase was not observed in both responders and non-responders during the course of CRT, supporting previous study that inflammation-induced SUV may have minimal impact in rectal cancer, or due to the partial volume effect to small lesions. (3) Future study with large cohort is needed to make statistical conclusion for our findings.

Dynamic Contrast-Enhanced Mri: Use in Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer

Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI

Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial.

Value of perfusion parameters from golden-angle radial sparse parallel dynamic contrast-enhanced magnetic resonance imaging in predicting pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer

Predicting treatment response for the safe non-operative management of patients with rectal cancer using an MRI-based deep-learning model.

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis

Assessment of pathological complete response to preoperative chemoradiotherapy by means of multiple mathematical models of diffusion-weighted MRI in locally advanced rectal cancer: A prospective single-center study.

Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.

Combined use of DWI , DCE-MRI , and PET / CT in treatment response for preoperative chemoradiation in primary rectal adenocarcinoma

MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.

Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer

Preoperative Evaluation of Pathologic Response in Patients with Breast Cancer by Dynamic Contrast-enhanced Magnetic Resonance Imaging

Diffusion-weighted Magnetic Resonance Imaging for Predicting the Response of Rectal Cancer to Neoadjuvant Concurrent Chemoradiation

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection

Prediction of pathologic complete response to neoadjuvant chemoradiation in locally advanced rectal cancer

Arterial Mucosal Linear Enhancement at Contrast-enhanced MRI to Exclude Residual Tumor after Neoadjuvant Chemotherapy and Radiation Therapy for Rectal Cancer

Molecular Diagnosis of Response to Neoadjuvant Chemoradiation Therapy in Patients with Locally Advanced Rectal Cancer.

Dynamic contrast-enhanced MRI early predicts short-term control of nasopharyngeal carcinoma treated with neoadjuvant chemotherapy followed by intensity-modulated radiotherapy